Access cutting-edge systemic lupus erythematosus treatment through this clinical trial at a research site in Stamford. Study-provided care at no cost to qualified participants.
Access systemic lupus erythematosus specialists in Stamford at no cost
This study follows strict safety protocols and ethical guidelines
All study-related systemic lupus erythematosus treatment provided free
The trial will evaluate efficacy, safety and tolerability of two regimens of ianalumab compared to placebo, given as monthly or quarterly subcutaneous (s.c.) injection on top of standard-of-care (SoC) treatment in participants with active systemic lupus erythematosus (SLE).
Sponsor: Novartis Pharmaceuticals
Check if you qualify for this systemic lupus erythematosus clinical trial in Stamford, CT
If you're searching for systemic lupus erythematosus treatment options in Stamford, CT, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Stamford research site is actively enrolling participants for this clinical trial. You'll receive care from experienced systemic lupus erythematosus specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.